Share Prices & Company Research

Stockbroking

Mereo Biopharma Group

Current Price 19.00p Bid 18.00p Ask 21.00p Change 1.60%
Last Updated: 27/05/2020 22:37. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Financial Highlights Year Ended 31/12/2018

Revenue
£n/am
Operating Profit/Loss
£-35.21m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
n/a

Key Personnel

Dr. Denise Scots-Knight
Chief Executive Officer
Mr Richard Jones
Chief Financial Officer
Mr Stephen Morgan
Chief Financial Officer and Senior Vice President
Dr Deepa Pakianathan
Independent Non-Executive Director
Mr Anders Ekblom
Independent Non-Executive Director
Mr Paul Blackburn
Independent Non-Executive Director
Mr Peter Bains
Independent Non-Executive Director
Mr Michael Wyzga
Interim CFO
Dr Peter J Fellner
Non-Executive Chairman
Mr Kunal Kashyap
Non-Executive Director

Stock Details

EPIC
MPH
ISIN
GB00BZ4G2K23
Shares in Issue
124.51m
Market cap
£23.66m

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
19.00p
Bid Price
18.00p
Ask Price
21.00p
Volume
198,076
Change Today
0.30p
% Change Today
1.60%
Open
18.70p
Previous Close
19.00p
Intraday High
19.00p
Intraday Low
17.50p
52 Week High
82.50p
52 Week Low
17.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

News

Income Statement

Year End Date
31 Dec 2018
31 Dec 2017
 
£ (M)
£ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
-35.21
-45.30
Net Interest
-2.05
-0.26
Pre-Tax Profit
-37.31
-46.95
Profit After Tax from continuing operations
-32.03
-38.80
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-32.03
-38.80
Attributable to:
Equity Holders of Parent Company
-32.03
-38.80
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2018
31 Dec 2017
Basic
-45.00p
-56.00p
Diluted
-45.00p
-56.00p
Adjusted
-45.00p
-56.00p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Dec 2018
31 Dec 2017
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
0.15
0.15
Intangible Assets
32.63
33.01
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
1.68
2.48
Cash at Bank & In Hand
25.04
50.04
Current Asset Investments
2.50
2.50
Other Current Assets
5.28
8.15
Other Assets
n/a
n/a
Total Assets
67.28
96.34

Liabilities

Year End Date
31 Dec 2018
31 Dec 2017
 
£ (M)
£ (M)
Current Liabilities
Borrowings
6.84
1.94
Other Current Liabilities
9.34
7.68
Total Current Liabilities
16.18
9.62
Non-Current Liabilities
Borrowings
14.65
18.81
Provisions
2.64
4.08
Other Non-Current Liabilities
1.04
1.35
Total Non-Current Liabilities
18.33
24.24
Other Liabilities
n/a
n/a
Total Liabilities
34.51
33.85

Net Assets

Year End Date
31 Dec 2018
31 Dec 2017
 
£ (M)
£ (M)
Net Assets
32.77
62.48

Capital & Reserves

Year End Date
31 Dec 2018
31 Dec 2017
 
£ (M)
£ (M)
Share Capital
0.21
0.21
Share Premium Account
118.49
118.23
Other Reserves
25.29
23.36
Retained Earnings
-111.22
-79.32
Shareholders Funds
32.77
62.48
Minority Interests/Other Equity
n/a
n/a
Total Equity
32.77
62.48

Dividend History

Dividend Metrics

Year End Date
31 Dec 2018
31 Dec 2017
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 22nd May 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.